THU0293 Safety and Efficacy of Short-Term Treatment with Tocilizumab in Patients with Refractory Takayasu Arteritis

Background

Takayasu arteritis (TAK) is a granulomatous vasculitis that involves aorta and/or its main branches and usually affects young or middle-aged women (before 50 years of age). Tocilizumab (TOCI) (monoclonal antibodies to IL-6 receptor) is a promising agent for treatment of refractory TAK, also clinical experience is very limited.

Objectives

To evaluate the efficacy and safety of short-term treatment with TOCI in...